Pan-cancer antagonistic inhibition pattern of ATM-driven G2/M checkpoint pathway vs other DNA repair pathways

Marianna A Zolotovskaia1, Alexander A Modestov2, Maria V Suntsova3

  • 1Laboratory for Translational Genomic Bioinformatics, Moscow Institute of Physics and Technology, Dolgoprudny, Moscow Region 141701, Russia; Omicsway Corp., Walnut, CA, 91789, USA.

DNA Repair
|January 19, 2023
PubMed

Insights

Most DNA repair pathways are upregulated in cancers, but G2/M checkpoints and p53 pathways are notably downregulated. This suggests their critical roles in cancer progression and therapeutic resistance.

Area of Science:

  • Molecular Biology
  • Cancer Genomics
  • Biochemistry

Background:

  • DNA repair mechanisms are crucial for maintaining genome integrity.
  • These pathways can also promote cancer cell survival following genotoxic therapies.
  • Understanding DNA repair pathway dysregulation is key to cancer treatment strategies.

Purpose of the Study:

  • To investigate the activation status of 38 DNA repair pathways across nine human cancer types.
  • To compare DNA repair pathway activity in tumor samples versus normal tissues.
  • To identify specific pathways that are consistently altered during cancer development.

Main Methods:

  • Analysis of RNA sequencing and proteomic profiles from The Cancer Genome Atlas and Clinical Proteomic Tumor Analysis Consortium databases.
  • Screening of pathway activation levels in over 500 normal and 5700 tumor samples.
  • Statistical analysis to compare pathway activities between cancer types and normal tissues.

Main Results:

  • A congruent trend of G2/M arrest checkpoint pathway inhibition was observed in all analyzed cancer types compared to normal samples.
  • p53-mediated pathways showed relatively low activity across most cancer types.
  • Most other DNA repair pathways were found to be upregulated in the majority of cancer types.
  • The G2/M checkpoint pathway's downregulation was linked to antagonistic regulation of CCNB, CDK1, and GADD45 genes.
  • Loss-of-function mutations in ATM, TP53, and CDKN1A, and transforming mutations in cyclin B complex genes were identified.

Conclusions:

  • The activation of most DNA repair pathways is important for cancer progression.
  • The downregulation of the G2/M checkpoint and p53-related pathways represents a significant exception.
  • These findings highlight potential therapeutic targets and biomarkers for cancer treatment.

Related Concept Videos

DNA Damage can Stall the Cell Cycle02:37

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
9.2K
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
6.7K
Long-patch Base Excision Repair01:02

Long-patch Base Excision Repair

Since the discovery of the two BER pathways, there has been a debate about how a cell chooses one pathway over the other and the factors determining this selection. Numerous in vitro experiments have pointed out multiple determinants for the sub-pathway selection. These are:
7.1K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.9K
DNA Damage Can Stall the Cell Cycle02:37

DNA Damage Can Stall the Cell Cycle

2.6K
Restarting Stalled Replication Forks02:37

Restarting Stalled Replication Forks

DNA replication is initiated at sites containing predefined DNA sequences known as origins of replication. DNA is unwound at these sites by the minichromosome maintenance (MCM) helicase and other factors such as Cdc45 and the associated GINS complex.The unwound single strands are protected by replication protein A (RPA) until DNA polymerase starts synthesizing DNA at the 5’ end of the strand in the same direction as the replication fork. To prevent the replication fork from falling apart,...
5.9K